Literature DB >> 26766031

Meta-analysis indicates that SNP rs9939609 within FTO is not associated with major depressive disorder (MDD) in Asian population.

Yao Yao1, Yueqiang Wen1, Tingfu Du2, Ning Sun3, Hong Deng4, Joanne Ryan5, Shuquan Rao6.   

Abstract

BACKGROUND: Major depressive disorder (MDD) is one of the most prevalent psychiatric illnesses with heritability of up to 38%. The fat mass- and obesity-associated (FTO) gene, in particular the single nucleotide polymorphism (SNP) rs9939609, has been identified as a genetic risk loci associated with MDD. However, most prior studies have involved European and American populations. Whether rs9939609 is an true risk SNP for MDD in Asian populations remains inconclusive.
METHODS: In the present study, we conducted a meta-analysis of the association between rs9939609 and MDD in Asian populations by combining 5 available case-control samples totaling 6531 cases and 12,359 controls.
RESULTS: Our meta-analysis suggests that rs9939609 is not a risk SNP for MDD in Asian populations by fixed effect model (Z=1.04, P=0.30, OR=0.96, 95% CI=0.90-1.03). LIMITATIONS: The age distribution and gender ratios were not matched well in the combined samples of cases and controls. Publication bias might be also considered with only a relatively small number of association studies of FTO rs9939609 with MDD in Asian populations.
CONCLUSIONS: The absence of association of rs9939609 with MDD in our Asian populations suggests a potential genetic heterogeneity in the susceptibility of MDD on this locus.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Asian population; FTO; Major depressive disorder; Meta-analysis; rs9939609

Mesh:

Substances:

Year:  2015        PMID: 26766031     DOI: 10.1016/j.jad.2015.12.048

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  8 in total

Review 1.  N6-methyladenosine as a Novel Regulator of Brain Physiology and Diseases.

Authors:  Bing Han; Hong-Hong Yao
Journal:  Curr Med Sci       Date:  2020-07-17

Review 2.  N6-methyladenosine and Neurological Diseases.

Authors:  Nan Zhang; Chunhong Ding; Yuxin Zuo; Yu Peng; Lielian Zuo
Journal:  Mol Neurobiol       Date:  2022-01-15       Impact factor: 5.590

3.  Genetic association of rs1344706 in ZNF804A with bipolar disorder and schizophrenia susceptibility in Chinese populations.

Authors:  Shuquan Rao; Yao Yao; Joanne Ryan; Chunhui Jin; Yong Xu; Xinhe Huang; Jianxiu Guo; Yueqiang Wen; Canquan Mao; David Meyre; Fuquan Zhang
Journal:  Sci Rep       Date:  2017-01-25       Impact factor: 4.379

4.  Lack of Association of the Fat Mass and Obesity Associated (FTO) Gene rs9939609 Polymorphism with Breast Cancer Risk: a Systematic Review and Meta-Analysis Based on Case - Control Studies

Authors:  Jamal Jafari Nedooshan; Saeed Kargar; Hossein Neamatzadeh; Fatemeh Haghighi; Reihaneh Dehghani Mohammad Abadi; Niloofar Seddighi
Journal:  Asian Pac J Cancer Prev       Date:  2017-04-01

5.  Fat mass and obesity-associated (FTO) rs9939609 polymorphism modifies the relationship between body mass index and affective symptoms through the life course: a prospective birth cohort study.

Authors:  Shinsuke Koike; Marcus Richards; Andrew Wong; Rebecca Hardy
Journal:  Transl Psychiatry       Date:  2018-03-13       Impact factor: 6.222

Review 6.  Emerging Roles of FTO in Neuropsychiatric Disorders.

Authors:  Rui Chang; Zeyi Huang; Size Zhao; Ju Zou; Yukun Li; Sijie Tan
Journal:  Biomed Res Int       Date:  2022-04-26       Impact factor: 3.246

7.  Common variants in FKBP5 gene and major depressive disorder (MDD) susceptibility: a comprehensive meta-analysis.

Authors:  Shuquan Rao; Yao Yao; Joanne Ryan; Tao Li; Duan Wang; Chuan Zheng; Yong Xu; Qi Xu
Journal:  Sci Rep       Date:  2016-09-07       Impact factor: 4.379

Review 8.  FTO associations with obesity and telomere length.

Authors:  Yuling Zhou; Brett D Hambly; Craig S McLachlan
Journal:  J Biomed Sci       Date:  2017-09-01       Impact factor: 8.410

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.